Physician profile
John N Mann
NPI 1548779457
$1,315.44
in general payments reported to CMS, 2019-2025
14 companies · $74.39 in 2025
The $74.39 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.46 · 2022: $238 · 2023: $694 · 2024: $280 · 2025: $74.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,048.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $715.67 | 2023-2024 | Ellipsys Vascular Access System |
| Astrazeneca Pharmaceuticals Lp | $190.00 | 2021-2024 | Airsupra, Farxiga |
| W. L. Gore & Associates, INC. | $129.90 | 2022 | |
| Venturemed Group, INC. | $49.69 | 2025 | Flex Vessel Prep System |
| Shionogi INC | $43.47 | 2022 | |
| Surmodics, INC. | $27.22 | 2024 | Pounce Thrombectomy, Pounce Venous Thrombectomy System |
| Baxter Healthcare | $26.22 | 2023 | Floseal |
| Daiichi Sankyo INC. | $25.90 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.34 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.07 | 2023 | Gattex |
| Terumo Medical Corporation | $21.22 | 2025 | Tr Band, Angio-Seal |
| Mozarc Medical US LLC | $20.52 | 2023 | Palindrome |
| Gilead Sciences, INC. | $14.74 | 2021 | |
| Cagent Vascular INC | $3.48 | 2025 | Serrantor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.